BE869406A - Vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe c et procede pour sa preparation - Google Patents

Vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe c et procede pour sa preparation

Info

Publication number
BE869406A
BE869406A BE189615A BE189615A BE869406A BE 869406 A BE869406 A BE 869406A BE 189615 A BE189615 A BE 189615A BE 189615 A BE189615 A BE 189615A BE 869406 A BE869406 A BE 869406A
Authority
BE
Belgium
Prior art keywords
preparation
high molecular
molecular mass
vaccine against
against group
Prior art date
Application number
BE189615A
Other languages
English (en)
French (fr)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of BE869406A publication Critical patent/BE869406A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
BE189615A 1977-08-01 1978-07-31 Vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe c et procede pour sa preparation BE869406A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/820,665 US4123520A (en) 1977-08-01 1977-08-01 Method for preparing high molecular weight meningococcal Group C vaccine

Publications (1)

Publication Number Publication Date
BE869406A true BE869406A (fr) 1979-01-31

Family

ID=25231420

Family Applications (1)

Application Number Title Priority Date Filing Date
BE189615A BE869406A (fr) 1977-08-01 1978-07-31 Vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe c et procede pour sa preparation

Country Status (17)

Country Link
US (1) US4123520A (da)
JP (1) JPS5446893A (da)
AR (1) AR222974A1 (da)
BE (1) BE869406A (da)
CA (1) CA1112566A (da)
DE (1) DE2833545A1 (da)
DK (1) DK308578A (da)
EG (1) EG13435A (da)
FI (1) FI59024C (da)
FR (1) FR2399252A1 (da)
GB (1) GB2001530B (da)
IE (1) IE47149B1 (da)
IT (1) IT1107462B (da)
LU (1) LU80063A1 (da)
NL (1) NL7807419A (da)
ZA (1) ZA784324B (da)
ZM (1) ZM6778A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2460139A1 (fr) * 1979-06-29 1981-01-23 Pasteur Institut Fraction antigenique glycopeptidique vaccinante a tres grande immunogenicite isolee de cultures de germes pathogenes, procedes d'isolement de cette fraction et vaccins contenant ladite fraction
BE889979A (fr) * 1981-08-14 1982-02-15 Smith Kline Rit Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation
EP0109688A3 (en) * 1982-11-23 1986-12-03 The Wellcome Foundation Limited Improved complexes, processes for obtaining them and formulations containing such complexes
US5370871A (en) * 1983-01-24 1994-12-06 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
EP0145359B1 (en) * 1983-11-21 1991-01-16 The Wellcome Foundation Limited Improved complexes, processes for obtaining them and formulations containing such complexes
US4681761A (en) * 1985-10-24 1987-07-21 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine
FR2619122B1 (fr) * 1987-08-03 1990-03-09 Pasteur Institut Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede
US4877613A (en) * 1987-08-05 1989-10-31 Biotech Connections, Inc. Process for preparing veterinary acellular vaccines against gram-negative nonenteric pathogenic bacilli
US5225194A (en) * 1989-11-13 1993-07-06 Ldc Research Corporation Aqueous diafiltration process for preparing acellular vaccines, against selected bacterial diseases
US5506129A (en) * 1991-05-24 1996-04-09 Evans Medical Limited Virus production
US20040213806A1 (en) * 1998-08-28 2004-10-28 Smithkline Beecham Biologicals, S.A. Salmonella typhi vaccine compositions
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
RU2283135C1 (ru) * 2005-05-16 2006-09-10 Анатолий Эдуардович Аваков Способ выделения очищенных полисахаридов менингококков серогрупп а и с
LT2351578T (lt) * 2005-06-27 2017-04-10 Glaxosmithkline Biologicals S.A. Vakcinų gavimo būdas
US7491517B2 (en) * 2006-07-19 2009-02-17 Jeeri R Reddy Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636192A (en) * 1970-01-13 1972-01-18 Us Army Meningococcal polysaccharide vaccines

Also Published As

Publication number Publication date
GB2001530B (en) 1982-03-03
FR2399252A1 (fr) 1979-03-02
IE781541L (en) 1979-02-01
IT1107462B (it) 1985-11-25
FI59024C (fi) 1981-06-10
US4123520A (en) 1978-10-31
ZA784324B (en) 1980-03-26
IT7850445A0 (it) 1978-07-24
JPS5446893A (en) 1979-04-13
CA1112566A (en) 1981-11-17
ZM6778A1 (en) 1980-06-20
DK308578A (da) 1979-02-02
EG13435A (en) 1981-06-30
GB2001530A (en) 1979-02-07
FI782204A7 (fi) 1979-02-02
NL7807419A (nl) 1979-02-05
AR222974A1 (es) 1981-07-15
LU80063A1 (fr) 1979-05-15
FR2399252B1 (da) 1981-07-31
FI59024B (fi) 1981-02-27
IE47149B1 (en) 1983-12-28
DE2833545A1 (de) 1979-02-15

Similar Documents

Publication Publication Date Title
JPS5382792A (en) Novel antibiotics mazethramycins and process their preparation
DE2860900D1 (en) Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them
LU80063A1 (fr) Procede de preparation d'un vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe c
FR2340950A1 (fr) Esters du cefuroxime, leur procede de preparation et leur application en therapeutique
DE2860893D1 (en) Lipopeptides, process for their preparation and pharmaceutical compositions containing them
YU283378A (en) Process for obtaining purified capsular polysaccharide streptococcus pneumoniae
FR2289534A1 (fr) Procede de preparation de copolymeres de styrene et d'acrylonitrile
FR2286192A1 (fr) Systeme de test a l'o-nitrophenyl-b-d-galactopyranoside, son procede de preparation et son application
EP0001280A3 (en) 1-n-acylated-4-o-glycosyl-6-o-glycosyl-1,3-diaminocyclitol derivatives, process for their preparation and pharmaceutical compositions containing them
DE2961804D1 (en) N-(3-benzoylpropyl)-spiro-(dihydrobenzofuranpiperidines and -pyrrolidines), derivatives thereof, methods for their preparation and their use for medicines
FR2282887A1 (fr) Derives de tetrahydropyridine et de piperidine et procede pour leur preparation
BE836975A (fr) N - (pyrrolidinyl - 3 1-substitue) naphtalenecarboxamides-1 et quinoleinecarboxamides - 4 et procede de leur preparation
BE839836A (fr) Procede de preparation du tricosene-(9) et de l'heneicosene-(9)
FR2477536B1 (fr) Nouveaux derives acyles de carnitine, procede de preparation de ces derives et leur utilisation therapeutique
IL55862A0 (en) Novel 6-oxygenated-3,20-dioxo-pregnane derivatives, process for the preparation thereof, and pharmaceutical compositionss containing them
BE854812A (fr) Benzenesulfonylurees, leur procede de preparation et leur application therapeutique
BE871586A (fr) Vaccin contre haemophilus influenzae et procede pour sa preparation
DE2860726D1 (en) Antibacterially active amides, process for their preparation and pharmaceutical compositions containing said amides
BE839913A (fr) Vaccin polysaccharide de meningocoque
PT68267A (fr) Procede de preparation de derives d'oxadiazole-1,2,4 et leur application en therapeutique
EP0000500A3 (en) Cephalosprin derivatives, process for their preparation and pharmaceutical compositions containing them
ATE10498T1 (de) Durch purinbasen substituierte alkylamino-desoxy1.4;3.6-dianhydro-hexit-nitrate, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
EP0000791A3 (en) Medicament-substituted hapten conjugates, process for their preparation, their use as pharmaceuticals and hapten used in their preparation
IL54111A (en) 3,6-disubstituted-1,2,4-triazine-5-one-derivatives,process for their preparation and pharmaceutical compositions containing them
FI803483A7 (fi) Makrolidiantibiootit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset seokset.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MERCK & CO. INC.

Effective date: 19870731